MINI FUTURE OPTIONSSCHEIN PUT - BIOGEN IDEC | Delayed Deutsche Boerse AG 09:04:21 2024-06-04 EDT | ||
| 10.07 EUR | +1.61% |
|
| Current month | -5.71% | ||
| 1 month | -11.60% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-04 | 10.07 | +1.61% |
| 24-06-03 | 9.91 | -5.71% |
| 24-05-31 | 10.51 | -4.19% |
| 24-05-30 | 10.97 | -3.77% |
| 24-05-29 | 11.4 | +2.80% |
Delayed Quote Deutsche Boerse AG
Last update June 04, 2024 at 09:04 am
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ5S1G |
| ISIN | DE000DJ5S1G9 |
| Date issued | 2023-10-26 |
| Strike | 336.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 7.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.88 € |
|---|---|
| Lowest since issue | 6.28 € |
| Spread | 0.06 € |
| Spread % | 0.59% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
229.8
USD
Average target price
284.8
USD
Spread / Average Target
+23.93%
- Stock Market
- Certificates
- Certificat
